HCA Healthcare, Inc. (HCA)
| Previous close | 309.44 |
| Open | 312.00 |
| Bid | 310.36 x 800 |
| Ask | 311.23 x 1000 |
| Day's range | 308.10 - 310.42 |
| 52-week range | 215.96 - 335.83 |
| Volume | |
| Avg. volume | 1,031,598 |
| Market cap | 81.731B |
| Beta (5Y monthly) | 1.67 |
| PE ratio (TTM) | 15.41 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.64 (0.85%) |
| Ex-dividend date | 14 June 2024 |
| 1y target est | N/A |
- Business Wire
HCA Healthcare Reports First Quarter 2024 Results
NASHVILLE, Tenn., April 26, 2024--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.
- GlobeNewswire
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departmentsSAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the cou
- Business Wire
Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology
BOSTON & NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA, April 23, 2024--An automated tool that improves outbreak detection for hundreds of pathogens successfully served as an early warning system to find and respond to potential hospital outbreaks, as reported today in NEJM Evidence.
